PhilipMagnusGrantMD
Infectious Disease • Stanford, CAInstructor, Medicine - Infectious Diseases, Stanford University Medical Center
Are you Dr. Grant?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 52 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000Fax+1 650-725-6908
Summary
- Dr. Philip Grant, MD is an infectious disease specialist in Stanford, California. He is currently licensed to practice medicine in California. He is affiliated with Stanford Health Care and is an Instructor at Stanford University Medical Center.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Infectious Disease, 2006 - 2008
University of WashingtonResidency, Internal Medicine, 2000 - 2003
University of California San Francisco School of MedicineClass of 2000
Certifications & Licensure
CA State Medical License 2006 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Stanford Universities: The Stanford HIV Aging Cohort Start of enrollment: 2010 Dec 01
- Neurocognitive Effects and Tolerability of Efavirenz in Aging HIV-infected Individuals ("SHAC Neuro Study") Start of enrollment: 2013 Dec 01
- Response to Live Attenuated Influenza Vaccine in Tonsillar Tissues and Blood Start of enrollment: 2019 Apr 15
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsPrevalence of Emergent Dolutegravir Resistance Mutations in People Living with HIV: A Rapid Scoping Review.Carolyn Chu, Kaiming Tao, Vinie Kouamou, Ava Avalos, Jake Scott
Viruses. 2024-03-04 - 1 citationsAssociations between county-level public health expenditures and community health planning activities with COVID-19 incidence and mortality.Richard Liang, Mathew V Kiang, Philip Grant, Christian Jackson, David H Rehkopf
Preventive Medicine Reports. 2023-12-01 - 4 citationsFostemsavir: a first-in-class HIV-1 attachment inhibitor.Philip M Grant, Michael J Kozal
Current Opinion in HIV and AIDS. 2022-01-01
Press Mentions
New HIV Preventive Strategy Sparks Excitement — and Protests — at AIDS ConferenceJuly 24th, 2024- Do COVID Vaccines Work Against Omicron? What We Know so FarNovember 29th, 2021
- Despite New Study, Stanford Doctor Explains Why J&J Vaccine Is Still EffectiveJuly 21st, 2021
- Join now to see all
